SEC Comment Letter for AC Immune SA (ACIU) (CIK 0001651625) (ACIU) — Apr 30, 2021
AC Immune SA (ACIU) (CIK 0001651625)
Date: April 30, 2021 · CIK: 0001651625 · Accession: 0000000000-21-005539
AI Filing Summary & Sentiment
File numbers found in text: 333-255576
Letter
United States securities and exchange commission logo April 30, 2021 Joerg Hornstein Chief Financial Officer AC Immune SA EPFL Innovation Park, Building B 1015 Lausanne Switzerland Re:AC Immune SA Registration Statement on Form F-3 Filed April 28, 2021 File No. 333-255576 Dear Mr. Hornstein: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Kasey Robinson at 202-551-5880 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Derek Dostal
Show Raw Text
United States securities and exchange commission logo
April 30, 2021
Joerg Hornstein
Chief Financial Officer
AC Immune SA
EPFL Innovation Park, Building B
1015 Lausanne
Switzerland
Re:AC Immune SA
Registration Statement on Form F-3
Filed April 28, 2021
File No. 333-255576
Dear Mr. Hornstein:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Kasey Robinson at 202-551-5880 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Derek Dostal